RedHill Biopharma (RDHL) FCF Margin (2012 - 2022)
RedHill Biopharma's (RDHL) quarterly FCF Margin came in at 18.92% in Q4 2022, up 4839.0% year-on-year from 0.38% in Q4 2021, and up 44.72% on a QoQ basis from 34.22% in Q3 2022.
RedHill Biopharma (RDHL) FCF Margin (2012 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has 11 years of FCF Margin data on file, last reported at 18.92% in Q4 2022.
- On a quarterly basis, FCF Margin rose 4839.0% year-over-year to 18.92% in Q4 2022; TTM through Jun 2023 was 23.58%, a 4886.0% increase from a year earlier, with the FY2025 full-year figure at 3372.73%, down 325635.0% from the prior year.
- FCF Margin for Q4 2022 stood at 18.92%, up from 34.22% in the prior quarter.
- Over the last five years, FCF Margin for RDHL reached as high as 18.92% in Q4 2022 and fell as low as 983.14% in Q1 2020.
- Historically, FCF Margin has averaged 297.97% across 5 years, with a median of 88.72% in 2021.
- On a YoY basis, FCF Margin climbed as much as 163564 bps in 2018 and fell as far as 20682785 bps in 2018.
- Year by year, FCF Margin stood at 602.58% in 2018, then slumped by 44 bps to 870.19% in 2019, then soared by 93 bps to 58.97% in 2020, then dropped by 14 bps to 67.31% in 2021, then surged by 72 bps to 18.92% in 2022.
- Per Business Quant data, the three most recent FCF Margin figures were 18.92% in Q4 2022, 34.22% in Q3 2022, and 89.49% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 46.54% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -2.77% |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 1.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -18.92% |
| Sep 30, 2022 | -34.22% |
| Jun 30, 2022 | -89.49% |
| Mar 31, 2022 | -31.61% |
| Dec 31, 2021 | -67.31% |
| Sep 30, 2021 | -87.94% |
| Jun 30, 2021 | -87.88% |
| Mar 31, 2021 | -59.19% |
| Dec 31, 2020 | -58.97% |
| Sep 30, 2020 | -43.00% |
| Jun 30, 2020 | -71.82% |
| Mar 31, 2020 | -983.14% |
| Dec 31, 2019 | -870.19% |
| Sep 30, 2019 | -634.76% |
| Jun 30, 2019 | -660.59% |
| Mar 31, 2019 | -433.33% |
| Dec 31, 2018 | -602.58% |
| Sep 30, 2018 | -379.37% |
| Jun 30, 2018 | -357.32% |
| Mar 31, 2018 | -387.85% |